Response to: A more appropriate use of antibiotics in COVID-19 infection.

Pinxt, C M H; Bogie, R M M; Hanssen, N M J; Spaetgens, B

Pinxt, C M H; Bogie, R M M; Hanssen, N M J; Spaetgens, B.

Pinxt CMH; Department of Internal Medicine, Division of General Internal Medicine, Section Geriatric Medicine, Maastricht University Medical Centre, P.O. Box 5800, NL-6202 AZ Maastricht, The Netherlands.
Bogie RMM; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Maastricht University Medical Centre, P.O. Box 5800, NL-6202 AZ Maastricht, The Netherlands.
Hanssen NMJ; Diabetes Centre, Department of Vascular and Internal Medicine, Amsterdam University Medical Centre, P.O. Box 22660, NL-1100 DD Amsterdam, The Netherlands.
Spaetgens B; Diabetes Centre, Department of Vascular and Internal Medicine, Amsterdam University Medical Centre, P.O. Box 22660, NL-1100 DD Amsterdam, The Netherlands.

QJM ; 115(9): 637, 2022 09 22.

Article in English | MEDLINE | ID: covidwho-2037523

Subject(s)

COVID-19 Drug Treatment; Anti-Bacterial Agents/therapeutic use; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Limits: Humans Language: English Journal: QJM Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: Netherlands

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google